| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrophages | 53 | 2024 | 5802 | 3.090 |
Why?
|
| Atherosclerosis | 40 | 2024 | 3433 | 2.400 |
Why?
|
| Macrophage Activation | 12 | 2022 | 557 | 2.360 |
Why?
|
| Arteriosclerosis | 25 | 2004 | 1055 | 2.280 |
Why?
|
| Lipoproteins, HDL | 8 | 2023 | 682 | 1.860 |
Why?
|
| Myocytes, Smooth Muscle | 13 | 2020 | 703 | 1.770 |
Why?
|
| Poly(ADP-ribose) Polymerases | 4 | 2020 | 428 | 1.760 |
Why?
|
| Muscle, Smooth, Vascular | 29 | 2020 | 1494 | 1.750 |
Why?
|
| Receptors, Notch | 7 | 2019 | 751 | 1.740 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 6 | 2019 | 1657 | 1.670 |
Why?
|
| Mass Spectrometry | 8 | 2025 | 2202 | 1.320 |
Why?
|
| Proteomics | 19 | 2024 | 3912 | 1.320 |
Why?
|
| Plaque, Atherosclerotic | 11 | 2024 | 1551 | 1.230 |
Why?
|
| Cholesterol Ester Transfer Proteins | 2 | 2021 | 113 | 1.150 |
Why?
|
| Phosphatidylcholine-Sterol O-Acyltransferase | 3 | 2024 | 33 | 1.000 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2020 | 588 | 1.000 |
Why?
|
| PPAR alpha | 3 | 2021 | 177 | 0.990 |
Why?
|
| Vena Cava, Inferior | 2 | 2021 | 463 | 0.990 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2019 | 2892 | 0.980 |
Why?
|
| Calcinosis | 12 | 2024 | 1482 | 0.970 |
Why?
|
| Collagenases | 7 | 2009 | 221 | 0.880 |
Why?
|
| Collagen | 15 | 2017 | 2645 | 0.840 |
Why?
|
| Myosin Heavy Chains | 14 | 2004 | 404 | 0.820 |
Why?
|
| Animals | 205 | 2025 | 169285 | 0.810 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 15 | 2012 | 3251 | 0.780 |
Why?
|
| Apolipoprotein C-III | 8 | 2021 | 210 | 0.760 |
Why?
|
| Plasmodium falciparum | 31 | 2002 | 1741 | 0.760 |
Why?
|
| Coronary Artery Disease | 17 | 2024 | 6568 | 0.750 |
Why?
|
| Apolipoprotein A-I | 4 | 2024 | 305 | 0.750 |
Why?
|
| Lipoproteins, LDL | 7 | 2022 | 644 | 0.740 |
Why?
|
| Pharmacogenetics | 1 | 2025 | 683 | 0.710 |
Why?
|
| Vascular Grafting | 2 | 2024 | 163 | 0.700 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2021 | 90 | 0.690 |
Why?
|
| Systems Analysis | 1 | 2021 | 168 | 0.690 |
Why?
|
| Aorta, Abdominal | 6 | 2017 | 627 | 0.690 |
Why?
|
| Erythrocytes | 26 | 2002 | 2418 | 0.660 |
Why?
|
| Membrane Proteins | 9 | 2019 | 7876 | 0.660 |
Why?
|
| Vasculitis | 2 | 2016 | 525 | 0.650 |
Why?
|
| Indican | 1 | 2019 | 16 | 0.650 |
Why?
|
| Aortic Valve Stenosis | 9 | 2024 | 2032 | 0.650 |
Why?
|
| Dyslipidemias | 4 | 2019 | 873 | 0.640 |
Why?
|
| Receptors, LDL | 10 | 2022 | 493 | 0.640 |
Why?
|
| Cholesterol | 14 | 2023 | 2914 | 0.620 |
Why?
|
| Inflammation | 20 | 2024 | 10873 | 0.620 |
Why?
|
| Mice | 95 | 2025 | 82049 | 0.610 |
Why?
|
| Signal Transduction | 23 | 2025 | 23648 | 0.600 |
Why?
|
| Disease Models, Animal | 33 | 2024 | 18349 | 0.600 |
Why?
|
| Organic Anion Transporters | 1 | 2019 | 101 | 0.600 |
Why?
|
| Lipoproteins | 4 | 2024 | 880 | 0.600 |
Why?
|
| Saphenous Vein | 5 | 2015 | 519 | 0.590 |
Why?
|
| Rabbits | 31 | 2015 | 4773 | 0.570 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 6 | 2018 | 301 | 0.550 |
Why?
|
| Calcium-Binding Proteins | 8 | 2019 | 1083 | 0.550 |
Why?
|
| Drug Discovery | 1 | 2025 | 1068 | 0.550 |
Why?
|
| Endothelial Cells | 12 | 2025 | 3589 | 0.540 |
Why?
|
| Mice, Inbred C57BL | 38 | 2025 | 22380 | 0.520 |
Why?
|
| Neointima | 2 | 2021 | 133 | 0.520 |
Why?
|
| Insulin Resistance | 5 | 2019 | 3986 | 0.510 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 3604 | 0.500 |
Why?
|
| Aortic Valve | 10 | 2024 | 1970 | 0.500 |
Why?
|
| Malaria, Cerebral | 8 | 2001 | 136 | 0.500 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2025 | 1124 | 0.500 |
Why?
|
| Proprotein Convertases | 2 | 2016 | 95 | 0.500 |
Why?
|
| Cardiovascular Diseases | 10 | 2020 | 15662 | 0.500 |
Why?
|
| Cell-Derived Microparticles | 2 | 2016 | 160 | 0.490 |
Why?
|
| STAT1 Transcription Factor | 1 | 2016 | 343 | 0.490 |
Why?
|
| Matrix Metalloproteinase 2 | 3 | 2015 | 462 | 0.490 |
Why?
|
| Angiopoietins | 1 | 2015 | 86 | 0.480 |
Why?
|
| Anticholesteremic Agents | 5 | 2015 | 972 | 0.480 |
Why?
|
| Serine Endopeptidases | 2 | 2022 | 1027 | 0.480 |
Why?
|
| Muscle, Smooth | 10 | 2004 | 931 | 0.480 |
Why?
|
| Peptides | 6 | 2025 | 4354 | 0.470 |
Why?
|
| Antibodies, Neutralizing | 3 | 2014 | 2009 | 0.470 |
Why?
|
| Interferon-gamma | 4 | 2021 | 3161 | 0.470 |
Why?
|
| Apolipoproteins E | 16 | 2019 | 1461 | 0.470 |
Why?
|
| Cells, Cultured | 36 | 2024 | 19025 | 0.470 |
Why?
|
| Proteome | 6 | 2024 | 1890 | 0.460 |
Why?
|
| Lipids | 12 | 2019 | 3345 | 0.460 |
Why?
|
| Cholesterol, Dietary | 8 | 2010 | 224 | 0.460 |
Why?
|
| Foam Cells | 4 | 2013 | 68 | 0.450 |
Why?
|
| Serum Amyloid P-Component | 1 | 2014 | 46 | 0.450 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2025 | 2909 | 0.450 |
Why?
|
| Metabolic Diseases | 1 | 2020 | 684 | 0.450 |
Why?
|
| Endothelium, Vascular | 20 | 2020 | 4428 | 0.440 |
Why?
|
| Leukocytes, Mononuclear | 5 | 2022 | 1854 | 0.440 |
Why?
|
| Cardiovascular System | 2 | 2020 | 841 | 0.420 |
Why?
|
| Plasminogen | 1 | 2013 | 144 | 0.420 |
Why?
|
| src-Family Kinases | 1 | 2015 | 539 | 0.420 |
Why?
|
| Tunica Intima | 8 | 2009 | 459 | 0.410 |
Why?
|
| Antigens, Differentiation | 4 | 2015 | 921 | 0.410 |
Why?
|
| Mice, Knockout | 27 | 2022 | 14488 | 0.410 |
Why?
|
| Malaria | 16 | 2001 | 1249 | 0.410 |
Why?
|
| Antibodies, Protozoan | 8 | 2000 | 251 | 0.400 |
Why?
|
| Phenotype | 14 | 2025 | 16726 | 0.400 |
Why?
|
| Adipose Tissue, White | 1 | 2015 | 371 | 0.400 |
Why?
|
| Thromboplastin | 4 | 2004 | 289 | 0.400 |
Why?
|
| Humans | 178 | 2025 | 768171 | 0.390 |
Why?
|
| Vascular Diseases | 3 | 2013 | 1162 | 0.390 |
Why?
|
| Aorta, Thoracic | 5 | 2024 | 1112 | 0.380 |
Why?
|
| Heart Valve Diseases | 5 | 2023 | 1030 | 0.380 |
Why?
|
| Biomimetic Materials | 1 | 2013 | 173 | 0.380 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 1469 | 0.370 |
Why?
|
| Gastric Bypass | 1 | 2019 | 824 | 0.370 |
Why?
|
| Aorta | 16 | 2020 | 2045 | 0.360 |
Why?
|
| Quinolines | 2 | 2015 | 772 | 0.360 |
Why?
|
| Malaria, Falciparum | 10 | 2001 | 1077 | 0.360 |
Why?
|
| Arteries | 5 | 2020 | 1127 | 0.350 |
Why?
|
| Gene Regulatory Networks | 4 | 2025 | 1752 | 0.350 |
Why?
|
| Gene Expression Regulation | 12 | 2019 | 11930 | 0.350 |
Why?
|
| Collagen Type I | 3 | 2022 | 620 | 0.350 |
Why?
|
| Bone Marrow Cells | 6 | 2013 | 2414 | 0.340 |
Why?
|
| Diet, Atherogenic | 8 | 2008 | 92 | 0.340 |
Why?
|
| Hypolipidemic Agents | 5 | 2019 | 609 | 0.340 |
Why?
|
| Cell Differentiation | 16 | 2015 | 11677 | 0.340 |
Why?
|
| Spleen | 4 | 2021 | 2296 | 0.330 |
Why?
|
| Hyperlipidemias | 3 | 2004 | 772 | 0.330 |
Why?
|
| Lipid Metabolism | 6 | 2018 | 1904 | 0.330 |
Why?
|
| Antigens, Protozoan | 10 | 1999 | 315 | 0.320 |
Why?
|
| Cell Communication | 2 | 2015 | 1660 | 0.310 |
Why?
|
| Kidney Failure, Chronic | 4 | 2015 | 2496 | 0.310 |
Why?
|
| Myosins | 7 | 2004 | 408 | 0.300 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2015 | 707 | 0.300 |
Why?
|
| Cholesterol, LDL | 3 | 2017 | 2403 | 0.300 |
Why?
|
| Leukocytes | 5 | 2013 | 2034 | 0.290 |
Why?
|
| Endarterectomy, Carotid | 1 | 2013 | 556 | 0.290 |
Why?
|
| Radiopharmaceuticals | 2 | 2019 | 2735 | 0.290 |
Why?
|
| YY1 Transcription Factor | 1 | 2007 | 60 | 0.280 |
Why?
|
| Biology | 3 | 2023 | 292 | 0.280 |
Why?
|
| Osteogenesis | 7 | 2022 | 1295 | 0.280 |
Why?
|
| Fatty Liver | 1 | 2013 | 810 | 0.280 |
Why?
|
| Apolipoprotein A-II | 2 | 2024 | 41 | 0.270 |
Why?
|
| Diet, Fat-Restricted | 2 | 2000 | 328 | 0.270 |
Why?
|
| Calgranulin B | 2 | 2020 | 87 | 0.270 |
Why?
|
| Cathepsins | 4 | 2015 | 243 | 0.270 |
Why?
|
| Mitochondria | 4 | 2024 | 3683 | 0.270 |
Why?
|
| Microscopy, Electron | 22 | 2002 | 2560 | 0.270 |
Why?
|
| Carotid Stenosis | 3 | 2013 | 859 | 0.270 |
Why?
|
| Hypercholesterolemia | 7 | 2007 | 1145 | 0.260 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2007 | 379 | 0.260 |
Why?
|
| Angiotensin II | 4 | 2022 | 844 | 0.260 |
Why?
|
| Metal Nanoparticles | 1 | 2010 | 406 | 0.260 |
Why?
|
| beta Catenin | 3 | 2009 | 1047 | 0.260 |
Why?
|
| Rupture, Spontaneous | 2 | 2024 | 365 | 0.260 |
Why?
|
| Liver | 12 | 2021 | 7578 | 0.250 |
Why?
|
| Kinetics | 7 | 2023 | 6330 | 0.240 |
Why?
|
| Macaca mulatta | 9 | 1996 | 2363 | 0.240 |
Why?
|
| Cell Adhesion | 17 | 2012 | 3097 | 0.240 |
Why?
|
| Subtilisins | 2 | 2022 | 80 | 0.240 |
Why?
|
| Male | 78 | 2025 | 364731 | 0.240 |
Why?
|
| Stroke | 2 | 2024 | 9755 | 0.240 |
Why?
|
| Cyclins | 1 | 2007 | 606 | 0.240 |
Why?
|
| C-Reactive Protein | 4 | 2017 | 3858 | 0.240 |
Why?
|
| T-Lymphocytes | 8 | 2015 | 10266 | 0.240 |
Why?
|
| Testicular Hydrocele | 1 | 2004 | 27 | 0.240 |
Why?
|
| Plasmodium | 6 | 1994 | 248 | 0.230 |
Why?
|
| Retinal Neovascularization | 2 | 2024 | 288 | 0.230 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 2298 | 0.230 |
Why?
|
| Particle Size | 2 | 2021 | 1651 | 0.230 |
Why?
|
| Polycarboxylate Cement | 1 | 2024 | 18 | 0.230 |
Why?
|
| NF-kappa B | 5 | 2022 | 2494 | 0.230 |
Why?
|
| Leishmania | 2 | 2001 | 75 | 0.230 |
Why?
|
| Toxoplasma | 3 | 2001 | 159 | 0.230 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 5 | 2012 | 693 | 0.220 |
Why?
|
| Carotid Artery Diseases | 5 | 2019 | 879 | 0.220 |
Why?
|
| Monocytes | 12 | 2008 | 2605 | 0.220 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2007 | 565 | 0.220 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2025 | 1197 | 0.210 |
Why?
|
| Dynamins | 2 | 2021 | 141 | 0.210 |
Why?
|
| Bone Marrow Transplantation | 2 | 2010 | 2709 | 0.210 |
Why?
|
| Ophthalmic Solutions | 1 | 2024 | 312 | 0.210 |
Why?
|
| Matrix Metalloproteinase 9 | 7 | 2007 | 634 | 0.210 |
Why?
|
| Renal Dialysis | 1 | 2012 | 1791 | 0.210 |
Why?
|
| Oxidative Stress | 4 | 2017 | 3140 | 0.210 |
Why?
|
| Apolipoproteins A | 1 | 2023 | 96 | 0.210 |
Why?
|
| Serine C-Palmitoyltransferase | 1 | 2022 | 42 | 0.200 |
Why?
|
| Nervous System Diseases | 1 | 2013 | 1662 | 0.200 |
Why?
|
| Matrix Metalloproteinase 13 | 5 | 2011 | 101 | 0.200 |
Why?
|
| Molecular Weight | 7 | 2021 | 2173 | 0.200 |
Why?
|
| Methionine | 1 | 2024 | 573 | 0.200 |
Why?
|
| Butyrates | 2 | 2021 | 167 | 0.200 |
Why?
|
| Parasitemia | 3 | 2000 | 166 | 0.200 |
Why?
|
| Matrix Metalloproteinases | 3 | 2001 | 393 | 0.200 |
Why?
|
| Benzoxazoles | 2 | 2021 | 92 | 0.200 |
Why?
|
| Thymosin | 1 | 2022 | 47 | 0.200 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2025 | 548 | 0.200 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2009 | 1250 | 0.190 |
Why?
|
| Hep G2 Cells | 3 | 2021 | 378 | 0.190 |
Why?
|
| Hernia, Inguinal | 1 | 2004 | 224 | 0.190 |
Why?
|
| Elastin | 4 | 2011 | 299 | 0.190 |
Why?
|
| Carnitine Acyltransferases | 1 | 2020 | 8 | 0.190 |
Why?
|
| Immunohistochemistry | 24 | 2004 | 11095 | 0.180 |
Why?
|
| Multiprotein Complexes | 1 | 2007 | 1110 | 0.180 |
Why?
|
| Deuterium | 1 | 2021 | 106 | 0.180 |
Why?
|
| Sphingolipids | 1 | 2022 | 178 | 0.180 |
Why?
|
| Lipoprotein(a) | 2 | 2023 | 489 | 0.180 |
Why?
|
| Mitochondria, Liver | 1 | 2021 | 190 | 0.180 |
Why?
|
| Apolipoproteins | 1 | 2023 | 328 | 0.180 |
Why?
|
| Receptors, Complement 3b | 1 | 2001 | 136 | 0.180 |
Why?
|
| Trypanosoma cruzi | 2 | 2001 | 204 | 0.180 |
Why?
|
| Cholesterol, HDL | 2 | 2024 | 1820 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 2459 | 0.180 |
Why?
|
| Protozoan Proteins | 10 | 1999 | 844 | 0.180 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2019 | 28 | 0.170 |
Why?
|
| RNA Interference | 4 | 2016 | 2832 | 0.170 |
Why?
|
| Thrombospondins | 7 | 1996 | 196 | 0.170 |
Why?
|
| Endothelium, Lymphatic | 1 | 2020 | 63 | 0.170 |
Why?
|
| Amino Acid Sequence | 18 | 2022 | 13422 | 0.170 |
Why?
|
| Veins | 2 | 2024 | 769 | 0.170 |
Why?
|
| Carotid Arteries | 4 | 2019 | 942 | 0.170 |
Why?
|
| Metalloendopeptidases | 2 | 1999 | 386 | 0.170 |
Why?
|
| Coronary Thrombosis | 1 | 2003 | 440 | 0.170 |
Why?
|
| Inflammasomes | 2 | 2023 | 540 | 0.170 |
Why?
|
| Quinazolinones | 1 | 2021 | 219 | 0.170 |
Why?
|
| Apolipoprotein B-100 | 3 | 2024 | 157 | 0.170 |
Why?
|
| Thrombosis | 8 | 2016 | 2957 | 0.170 |
Why?
|
| Retinopathy of Prematurity | 1 | 2024 | 449 | 0.160 |
Why?
|
| Retinoids | 1 | 2019 | 99 | 0.160 |
Why?
|
| Gene Expression Profiling | 5 | 2020 | 9540 | 0.160 |
Why?
|
| Cell Adhesion Molecules | 6 | 2006 | 1613 | 0.160 |
Why?
|
| Chemokine CCL2 | 4 | 2015 | 605 | 0.160 |
Why?
|
| Myocardial Infarction | 9 | 2022 | 11519 | 0.160 |
Why?
|
| Blood Chemical Analysis | 1 | 2021 | 435 | 0.160 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2019 | 229 | 0.160 |
Why?
|
| Protein Precursors | 2 | 2022 | 1135 | 0.160 |
Why?
|
| Recombinant Proteins | 7 | 2024 | 6512 | 0.160 |
Why?
|
| CD40 Ligand | 3 | 2007 | 528 | 0.160 |
Why?
|
| Gluconeogenesis | 1 | 2019 | 185 | 0.160 |
Why?
|
| Ascorbic Acid | 1 | 2002 | 658 | 0.160 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2019 | 208 | 0.150 |
Why?
|
| Adipose Tissue, Brown | 1 | 2024 | 776 | 0.150 |
Why?
|
| Extracellular Matrix | 8 | 2016 | 1738 | 0.150 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2015 | 1169 | 0.150 |
Why?
|
| Gene Deletion | 2 | 2005 | 2674 | 0.150 |
Why?
|
| Inflammation Mediators | 2 | 2019 | 1892 | 0.150 |
Why?
|
| Blood Vessels | 1 | 2004 | 1110 | 0.150 |
Why?
|
| Heart Valves | 3 | 2006 | 284 | 0.150 |
Why?
|
| Energy Metabolism | 2 | 2020 | 2907 | 0.150 |
Why?
|
| Transplantation | 1 | 2020 | 221 | 0.150 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2019 | 223 | 0.150 |
Why?
|
| Multiple Organ Failure | 1 | 2020 | 388 | 0.150 |
Why?
|
| Sphingosine | 1 | 2020 | 308 | 0.150 |
Why?
|
| Estrogen Receptor alpha | 1 | 2022 | 581 | 0.150 |
Why?
|
| Aortic Diseases | 3 | 2017 | 742 | 0.150 |
Why?
|
| Cross-Over Studies | 1 | 2024 | 2107 | 0.150 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1998 | 492 | 0.140 |
Why?
|
| Phosphorylation | 6 | 2016 | 8316 | 0.140 |
Why?
|
| Cell Line | 14 | 2014 | 15602 | 0.140 |
Why?
|
| Lysophospholipids | 1 | 2020 | 338 | 0.140 |
Why?
|
| Retinal Diseases | 1 | 2023 | 710 | 0.140 |
Why?
|
| Workflow | 2 | 2020 | 860 | 0.140 |
Why?
|
| Cell Movement | 4 | 2015 | 5213 | 0.140 |
Why?
|
| Obesity | 4 | 2018 | 13091 | 0.140 |
Why?
|
| Computational Biology | 3 | 2025 | 3567 | 0.140 |
Why?
|
| Platelet Membrane Glycoproteins | 3 | 1992 | 283 | 0.140 |
Why?
|
| Antigens, CD | 5 | 2005 | 4035 | 0.140 |
Why?
|
| Dexamethasone | 1 | 2024 | 1965 | 0.140 |
Why?
|
| Ribose | 1 | 2016 | 63 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2023 | 4355 | 0.140 |
Why?
|
| RNA, Messenger | 19 | 2022 | 12801 | 0.140 |
Why?
|
| Coronavirus | 1 | 2019 | 156 | 0.140 |
Why?
|
| Proteins | 7 | 2024 | 6009 | 0.130 |
Why?
|
| Positron-Emission Tomography | 1 | 2013 | 6669 | 0.130 |
Why?
|
| Coronary Vessels | 7 | 2019 | 3124 | 0.130 |
Why?
|
| Apolipoproteins C | 2 | 2006 | 59 | 0.130 |
Why?
|
| Anastomosis, Surgical | 1 | 2020 | 991 | 0.130 |
Why?
|
| Antibodies | 8 | 2015 | 2421 | 0.130 |
Why?
|
| Diphosphonates | 1 | 2021 | 634 | 0.130 |
Why?
|
| Receptors, Cell Surface | 6 | 2005 | 2819 | 0.130 |
Why?
|
| Systems Biology | 1 | 2020 | 482 | 0.130 |
Why?
|
| Fluorine Radioisotopes | 1 | 2019 | 425 | 0.130 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 1994 | 354 | 0.130 |
Why?
|
| Matrix Metalloproteinase 3 | 3 | 2001 | 139 | 0.130 |
Why?
|
| Immunoglobulin G | 5 | 2000 | 4568 | 0.130 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2015 | 63 | 0.120 |
Why?
|
| Endoplasmic Reticulum | 1 | 2021 | 1133 | 0.120 |
Why?
|
| Zebrafish Proteins | 2 | 1999 | 1019 | 0.120 |
Why?
|
| Interferons | 1 | 2019 | 720 | 0.120 |
Why?
|
| Primary Prevention | 1 | 2003 | 1188 | 0.120 |
Why?
|
| Melanoma, Amelanotic | 1 | 1994 | 19 | 0.120 |
Why?
|
| Fibrosis | 7 | 2023 | 2081 | 0.120 |
Why?
|
| Trans-Activators | 3 | 1999 | 2857 | 0.120 |
Why?
|
| Apolipoproteins B | 3 | 2008 | 386 | 0.120 |
Why?
|
| Cross-Linking Reagents | 1 | 2018 | 693 | 0.120 |
Why?
|
| Dietary Carbohydrates | 1 | 2019 | 896 | 0.120 |
Why?
|
| Histology | 1 | 2014 | 16 | 0.120 |
Why?
|
| Molecular Sequence Data | 22 | 1999 | 17623 | 0.110 |
Why?
|
| Heat-Shock Proteins | 5 | 2001 | 797 | 0.110 |
Why?
|
| Mice, Transgenic | 7 | 2020 | 9561 | 0.110 |
Why?
|
| Endophenotypes | 1 | 2016 | 259 | 0.110 |
Why?
|
| Software | 3 | 2018 | 4480 | 0.110 |
Why?
|
| Immunity, Innate | 3 | 2019 | 3080 | 0.110 |
Why?
|
| Graft Survival | 3 | 2021 | 3887 | 0.110 |
Why?
|
| Cystathionine gamma-Lyase | 1 | 2013 | 38 | 0.110 |
Why?
|
| Lipogenesis | 1 | 2015 | 217 | 0.110 |
Why?
|
| GTP Phosphohydrolases | 1 | 2017 | 525 | 0.110 |
Why?
|
| Crosses, Genetic | 4 | 2015 | 752 | 0.110 |
Why?
|
| Virus Diseases | 1 | 2020 | 724 | 0.110 |
Why?
|
| Hepatitis | 1 | 2015 | 227 | 0.110 |
Why?
|
| Female | 48 | 2024 | 397187 | 0.110 |
Why?
|
| Cell Division | 7 | 2001 | 4477 | 0.110 |
Why?
|
| RNA | 1 | 2023 | 2722 | 0.110 |
Why?
|
| Wound Healing | 1 | 2025 | 2815 | 0.110 |
Why?
|
| Cytoskeletal Proteins | 2 | 1999 | 1327 | 0.110 |
Why?
|
| Immunoglobulin E | 1 | 2000 | 1506 | 0.110 |
Why?
|
| Macrophages, Peritoneal | 3 | 2015 | 244 | 0.110 |
Why?
|
| Intercellular Adhesion Molecule-1 | 6 | 2006 | 1134 | 0.110 |
Why?
|
| Adipose Tissue | 2 | 2018 | 3334 | 0.110 |
Why?
|
| Bone Resorption | 1 | 2017 | 728 | 0.110 |
Why?
|
| Membrane Glycoproteins | 7 | 2000 | 3713 | 0.110 |
Why?
|
| Diabetes Complications | 1 | 2020 | 1320 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2005 | 4528 | 0.110 |
Why?
|
| Annexin A5 | 1 | 2013 | 104 | 0.110 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2013 | 72 | 0.110 |
Why?
|
| Enzyme Assays | 1 | 2014 | 103 | 0.110 |
Why?
|
| Esophageal Stenosis | 1 | 2014 | 196 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2009 | 414 | 0.100 |
Why?
|
| Fatty Acids | 1 | 2020 | 1812 | 0.100 |
Why?
|
| Protein Multimerization | 1 | 2018 | 966 | 0.100 |
Why?
|
| Interleukin-4 | 1 | 2016 | 1156 | 0.100 |
Why?
|
| Morphogenesis | 1 | 2016 | 747 | 0.100 |
Why?
|
| Esophagoscopy | 1 | 2014 | 398 | 0.100 |
Why?
|
| Transcription Factors | 6 | 2023 | 12171 | 0.100 |
Why?
|
| Microscopy, Atomic Force | 3 | 2002 | 250 | 0.100 |
Why?
|
| Rats | 18 | 2015 | 23782 | 0.100 |
Why?
|
| Absorbable Implants | 1 | 2014 | 338 | 0.100 |
Why?
|
| Oxygen | 4 | 2024 | 4270 | 0.100 |
Why?
|
| Single-Cell Analysis | 2 | 2020 | 2540 | 0.100 |
Why?
|
| Glucose Tolerance Test | 1 | 2015 | 1183 | 0.100 |
Why?
|
| Luciferases | 1 | 2014 | 713 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 11 | 1994 | 2474 | 0.100 |
Why?
|
| Apoptosis | 5 | 2016 | 9527 | 0.100 |
Why?
|
| Phagocytosis | 5 | 2024 | 1530 | 0.100 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 1074 | 0.100 |
Why?
|
| 3T3-L1 Cells | 1 | 2012 | 208 | 0.100 |
Why?
|
| Adipocytes | 2 | 2024 | 1199 | 0.100 |
Why?
|
| Isodesmosine | 1 | 2011 | 6 | 0.100 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2012 | 660 | 0.100 |
Why?
|
| Desmosine | 1 | 2011 | 19 | 0.100 |
Why?
|
| Giardia lamblia | 1 | 1991 | 23 | 0.100 |
Why?
|
| Entamoeba histolytica | 1 | 1991 | 28 | 0.100 |
Why?
|
| Pyridines | 4 | 2004 | 2894 | 0.100 |
Why?
|
| Matrix Metalloproteinase 12 | 1 | 2011 | 44 | 0.100 |
Why?
|
| Matrix Metalloproteinase 14 | 2 | 2009 | 59 | 0.090 |
Why?
|
| Berberine | 1 | 1991 | 26 | 0.090 |
Why?
|
| Peripheral Arterial Disease | 1 | 2023 | 1304 | 0.090 |
Why?
|
| Antigen-Antibody Reactions | 2 | 1989 | 342 | 0.090 |
Why?
|
| Mice, Obese | 1 | 2012 | 418 | 0.090 |
Why?
|
| Actins | 7 | 2005 | 2064 | 0.090 |
Why?
|
| Research | 1 | 2020 | 1979 | 0.090 |
Why?
|
| Mitochondrial Proteins | 1 | 2017 | 979 | 0.090 |
Why?
|
| Virus Replication | 1 | 2019 | 2458 | 0.090 |
Why?
|
| Myocardium | 8 | 2003 | 4790 | 0.090 |
Why?
|
| Adenoviridae | 1 | 2015 | 1093 | 0.090 |
Why?
|
| Trichomonas vaginalis | 1 | 1991 | 70 | 0.090 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2022 | 835 | 0.090 |
Why?
|
| Cell Survival | 3 | 2016 | 5789 | 0.090 |
Why?
|
| Receptors, Lipoprotein | 2 | 2001 | 88 | 0.090 |
Why?
|
| Matrix Metalloproteinase 1 | 2 | 2001 | 147 | 0.090 |
Why?
|
| Leukocyte Elastase | 1 | 2011 | 114 | 0.090 |
Why?
|
| Intestines | 1 | 2019 | 1909 | 0.090 |
Why?
|
| Constriction, Pathologic | 3 | 2023 | 1104 | 0.090 |
Why?
|
| Severity of Illness Index | 5 | 2020 | 15949 | 0.090 |
Why?
|
| Microscopy, Immunoelectron | 9 | 1999 | 316 | 0.090 |
Why?
|
| Transfection | 4 | 2015 | 5756 | 0.090 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 1997 | 1724 | 0.090 |
Why?
|
| Brain Diseases | 2 | 1990 | 1554 | 0.090 |
Why?
|
| Hypertrophy, Left Ventricular | 3 | 2000 | 856 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 12 | 2004 | 9262 | 0.090 |
Why?
|
| Cerebrovascular Disorders | 1 | 2017 | 1485 | 0.090 |
Why?
|
| Phospholipids | 3 | 2015 | 787 | 0.080 |
Why?
|
| Fetus | 4 | 2006 | 1883 | 0.080 |
Why?
|
| Protein Binding | 6 | 2022 | 9343 | 0.080 |
Why?
|
| Osteoclasts | 1 | 2013 | 713 | 0.080 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2024 | 2442 | 0.080 |
Why?
|
| Protein Kinase C-alpha | 2 | 2006 | 113 | 0.080 |
Why?
|
| Cloning, Molecular | 8 | 1999 | 4168 | 0.080 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2009 | 60 | 0.080 |
Why?
|
| Ferrosoferric Oxide | 1 | 2010 | 348 | 0.080 |
Why?
|
| Antigens, Surface | 3 | 1996 | 1617 | 0.080 |
Why?
|
| Genetic Vectors | 2 | 2016 | 3403 | 0.080 |
Why?
|
| Models, Biological | 3 | 2022 | 9497 | 0.080 |
Why?
|
| Cell Membrane | 7 | 2009 | 3655 | 0.080 |
Why?
|
| Splenectomy | 4 | 1996 | 392 | 0.080 |
Why?
|
| Fibroblasts | 4 | 2007 | 4178 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2010 | 36741 | 0.080 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2010 | 507 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 9 | 2007 | 6082 | 0.080 |
Why?
|
| User-Computer Interface | 1 | 2015 | 1407 | 0.080 |
Why?
|
| Gene Expression | 9 | 2010 | 7601 | 0.080 |
Why?
|
| Fluorobenzenes | 1 | 2010 | 179 | 0.080 |
Why?
|
| Esophagus | 1 | 2014 | 1042 | 0.080 |
Why?
|
| Neovascularization, Physiologic | 3 | 2025 | 1370 | 0.080 |
Why?
|
| Schistosoma mansoni | 2 | 1990 | 156 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2001 | 3409 | 0.080 |
Why?
|
| Sp1 Transcription Factor | 2 | 2007 | 143 | 0.080 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2009 | 99 | 0.080 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 1887 | 0.080 |
Why?
|
| Reactive Oxygen Species | 3 | 2011 | 2152 | 0.070 |
Why?
|
| Receptors, Prostaglandin E | 1 | 2008 | 56 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 4648 | 0.070 |
Why?
|
| Tyrosine | 1 | 2012 | 1427 | 0.070 |
Why?
|
| Adult | 27 | 2024 | 223646 | 0.070 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2012 | 577 | 0.070 |
Why?
|
| Histocytochemistry | 1 | 2009 | 699 | 0.070 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2008 | 103 | 0.070 |
Why?
|
| Receptors, Immunologic | 3 | 2001 | 1418 | 0.070 |
Why?
|
| Cadherins | 1 | 2012 | 905 | 0.070 |
Why?
|
| Cyclin D | 1 | 2007 | 71 | 0.070 |
Why?
|
| TNF Receptor-Associated Factor 5 | 1 | 2007 | 5 | 0.070 |
Why?
|
| Risk Factors | 7 | 2023 | 74944 | 0.070 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 2007 | 38 | 0.070 |
Why?
|
| TNF Receptor-Associated Factor 1 | 1 | 2007 | 48 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2023 | 3803 | 0.070 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2007 | 56 | 0.070 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 2007 | 93 | 0.070 |
Why?
|
| Thymidine Kinase | 1 | 2007 | 286 | 0.070 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2007 | 61 | 0.070 |
Why?
|
| Enzyme Inhibitors | 2 | 2011 | 3728 | 0.070 |
Why?
|
| Cell Hypoxia | 1 | 2009 | 662 | 0.070 |
Why?
|
| Pertussis Toxin | 1 | 2006 | 176 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2023 | 1966 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 6 | 2017 | 3814 | 0.070 |
Why?
|
| Plasmodium berghei | 4 | 1993 | 161 | 0.070 |
Why?
|
| Connective Tissue | 1 | 2009 | 425 | 0.070 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2007 | 287 | 0.070 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2008 | 348 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 7 | 2001 | 6231 | 0.070 |
Why?
|
| Macrophage-1 Antigen | 1 | 2007 | 286 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2014 | 1667 | 0.070 |
Why?
|
| Immunoblotting | 6 | 1999 | 1648 | 0.070 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 1998 | 617 | 0.060 |
Why?
|
| Response Elements | 1 | 2007 | 308 | 0.060 |
Why?
|
| Transcription, Genetic | 3 | 2013 | 7609 | 0.060 |
Why?
|
| Endosomes | 1 | 2009 | 522 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2015 | 8142 | 0.060 |
Why?
|
| Glomerulonephritis | 2 | 1996 | 333 | 0.060 |
Why?
|
| Myosin Subfragments | 2 | 1995 | 20 | 0.060 |
Why?
|
| Comorbidity | 1 | 2020 | 10590 | 0.060 |
Why?
|
| Eosinophils | 2 | 1981 | 952 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2017 | 9669 | 0.060 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 693 | 0.060 |
Why?
|
| Peptide Fragments | 2 | 2016 | 5151 | 0.060 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 2025 | 70 | 0.060 |
Why?
|
| Cell Proliferation | 3 | 2020 | 10478 | 0.060 |
Why?
|
| Neutrophils | 6 | 2004 | 3786 | 0.060 |
Why?
|
| Peritoneum | 2 | 2004 | 230 | 0.060 |
Why?
|
| Coronary Disease | 5 | 2016 | 5919 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2019 | 6431 | 0.060 |
Why?
|
| Disease Progression | 6 | 2010 | 13668 | 0.060 |
Why?
|
| Tretinoin | 2 | 2019 | 525 | 0.060 |
Why?
|
| Ventricular Remodeling | 2 | 2003 | 1282 | 0.060 |
Why?
|
| Alkaline Phosphatase | 2 | 2019 | 864 | 0.060 |
Why?
|
| Middle Aged | 20 | 2024 | 223487 | 0.060 |
Why?
|
| Peroxidase | 2 | 2007 | 610 | 0.060 |
Why?
|
| Fucose | 1 | 2005 | 122 | 0.060 |
Why?
|
| Kidney Glomerulus | 4 | 1996 | 570 | 0.060 |
Why?
|
| Time Factors | 8 | 2017 | 40220 | 0.060 |
Why?
|
| Hypochlorous Acid | 1 | 2004 | 14 | 0.060 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2007 | 752 | 0.060 |
Why?
|
| Protease Inhibitors | 3 | 2015 | 751 | 0.060 |
Why?
|
| Cell Cycle Proteins | 2 | 2023 | 3445 | 0.060 |
Why?
|
| CADASIL | 1 | 2005 | 83 | 0.060 |
Why?
|
| Cholesterol Esters | 1 | 2024 | 72 | 0.060 |
Why?
|
| Base Sequence | 13 | 1999 | 12422 | 0.060 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2012 | 1816 | 0.060 |
Why?
|
| Iliac Artery | 1 | 2005 | 344 | 0.060 |
Why?
|
| RNA, Small Interfering | 4 | 2017 | 3428 | 0.060 |
Why?
|
| Peptide Hydrolases | 1 | 2007 | 610 | 0.060 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2005 | 167 | 0.060 |
Why?
|
| Heart Diseases | 1 | 2017 | 2819 | 0.060 |
Why?
|
| Ligands | 4 | 2012 | 3284 | 0.060 |
Why?
|
| Sequence Analysis, Protein | 1 | 2025 | 264 | 0.060 |
Why?
|
| Retinoblastoma Protein | 1 | 2007 | 671 | 0.060 |
Why?
|
| Risk Assessment | 6 | 2022 | 24318 | 0.050 |
Why?
|
| Thailand | 2 | 2001 | 288 | 0.050 |
Why?
|
| Chylomicrons | 1 | 2023 | 27 | 0.050 |
Why?
|
| Chaperonin 60 | 3 | 2001 | 97 | 0.050 |
Why?
|
| Pyruvic Acid | 1 | 2024 | 205 | 0.050 |
Why?
|
| Autoantibodies | 4 | 2002 | 2121 | 0.050 |
Why?
|
| Pulmonary Valve | 2 | 2004 | 413 | 0.050 |
Why?
|
| Trypanosoma | 1 | 1983 | 14 | 0.050 |
Why?
|
| Phenyl Ethers | 2 | 2002 | 62 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2023 | 3517 | 0.050 |
Why?
|
| Pyrogens | 1 | 1982 | 17 | 0.050 |
Why?
|
| S100 Proteins | 2 | 2009 | 216 | 0.050 |
Why?
|
| Administration, Topical | 1 | 2024 | 704 | 0.050 |
Why?
|
| Swine | 5 | 2021 | 5997 | 0.050 |
Why?
|
| Rosette Formation | 2 | 1994 | 152 | 0.050 |
Why?
|
| Relapsing Fever | 1 | 1982 | 25 | 0.050 |
Why?
|
| Hyperoxia | 1 | 2024 | 261 | 0.050 |
Why?
|
| Transforming Growth Factors | 1 | 2022 | 76 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2006 | 948 | 0.050 |
Why?
|
| Calcium | 5 | 2016 | 5792 | 0.050 |
Why?
|
| Onchocerca | 1 | 1981 | 3 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 4 | 2007 | 826 | 0.050 |
Why?
|
| Radiography | 1 | 2013 | 6986 | 0.050 |
Why?
|
| Borrelia | 1 | 1982 | 66 | 0.050 |
Why?
|
| Scurvy | 1 | 2002 | 36 | 0.050 |
Why?
|
| Culture Techniques | 1 | 2002 | 530 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1994 | 2334 | 0.050 |
Why?
|
| Plasmodium vivax | 3 | 1993 | 203 | 0.050 |
Why?
|
| Wnt1 Protein | 2 | 1999 | 123 | 0.050 |
Why?
|
| Secretory Pathway | 1 | 2021 | 53 | 0.050 |
Why?
|
| Transformation, Genetic | 2 | 1999 | 194 | 0.050 |
Why?
|
| Aged | 15 | 2024 | 171502 | 0.050 |
Why?
|
| Capillaries | 3 | 1996 | 755 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2019 | 3115 | 0.050 |
Why?
|
| Ceramides | 1 | 2022 | 203 | 0.050 |
Why?
|
| Plasmodium yoelii | 1 | 2001 | 41 | 0.050 |
Why?
|
| Static Electricity | 1 | 2002 | 260 | 0.050 |
Why?
|
| rab GTP-Binding Proteins | 2 | 2016 | 247 | 0.050 |
Why?
|
| Protein Transport | 2 | 2018 | 1951 | 0.050 |
Why?
|
| Life Cycle Stages | 1 | 2002 | 161 | 0.050 |
Why?
|
| Myxoma | 1 | 2001 | 114 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 1999 | 1683 | 0.050 |
Why?
|
| Surface Properties | 2 | 2001 | 1166 | 0.050 |
Why?
|
| Cell Death | 2 | 2004 | 1680 | 0.050 |
Why?
|
| Insulin | 1 | 2015 | 6610 | 0.050 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2001 | 205 | 0.050 |
Why?
|
| Disease Susceptibility | 3 | 2022 | 1793 | 0.050 |
Why?
|
| DNA Primers | 3 | 2001 | 2828 | 0.050 |
Why?
|
| Heart Transplantation | 3 | 2003 | 3301 | 0.040 |
Why?
|
| Azo Compounds | 1 | 2001 | 116 | 0.040 |
Why?
|
| Ions | 1 | 2021 | 256 | 0.040 |
Why?
|
| Sulfonamides | 1 | 2010 | 1982 | 0.040 |
Why?
|
| Polymorphism, Genetic | 2 | 2001 | 4249 | 0.040 |
Why?
|
| Rheumatic Heart Disease | 1 | 2022 | 164 | 0.040 |
Why?
|
| Stem Cells | 2 | 2005 | 3538 | 0.040 |
Why?
|
| Mutation | 3 | 2016 | 30237 | 0.040 |
Why?
|
| Adenosine Diphosphate | 1 | 2021 | 422 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2004 | 1751 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2009 | 2885 | 0.040 |
Why?
|
| Procollagen | 1 | 2001 | 189 | 0.040 |
Why?
|
| DNA, Complementary | 4 | 1999 | 1989 | 0.040 |
Why?
|
| Cell Count | 1 | 2004 | 1832 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2009 | 6229 | 0.040 |
Why?
|
| Genes, Reporter | 3 | 1999 | 1524 | 0.040 |
Why?
|
| Cytoplasmic Granules | 3 | 1998 | 574 | 0.040 |
Why?
|
| Trichinellosis | 1 | 1980 | 27 | 0.040 |
Why?
|
| Treatment Outcome | 6 | 2022 | 65379 | 0.040 |
Why?
|
| Carotid Artery, Common | 2 | 1998 | 174 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 1743 | 0.040 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2001 | 190 | 0.040 |
Why?
|
| Aging | 4 | 2006 | 8743 | 0.040 |
Why?
|
| Host-Parasite Interactions | 2 | 2001 | 303 | 0.040 |
Why?
|
| Hyperplasia | 2 | 2021 | 1151 | 0.040 |
Why?
|
| Models, Molecular | 2 | 2022 | 5402 | 0.040 |
Why?
|
| Complement C3 Nephritic Factor | 1 | 1979 | 13 | 0.040 |
Why?
|
| Sensitivity and Specificity | 6 | 2015 | 14729 | 0.040 |
Why?
|
| Spectrum Analysis | 1 | 2002 | 449 | 0.040 |
Why?
|
| Factor X | 1 | 1999 | 64 | 0.040 |
Why?
|
| Complement Inactivator Proteins | 1 | 1979 | 74 | 0.040 |
Why?
|
| Cricetinae | 4 | 2007 | 2423 | 0.040 |
Why?
|
| Coronary Stenosis | 1 | 2005 | 802 | 0.040 |
Why?
|
| Macaca | 3 | 2000 | 413 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 911 | 0.040 |
Why?
|
| Asparagine | 1 | 1999 | 120 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2025 | 1151 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2002 | 706 | 0.040 |
Why?
|
| Clusterin | 1 | 2019 | 72 | 0.040 |
Why?
|
| Oropharynx | 1 | 2000 | 139 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 5 | 2019 | 5797 | 0.040 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2018 | 563 | 0.040 |
Why?
|
| Brain | 9 | 1996 | 27362 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 2 | 2004 | 420 | 0.040 |
Why?
|
| Phosphates | 2 | 2015 | 765 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2024 | 872 | 0.040 |
Why?
|
| Pravastatin | 1 | 2001 | 393 | 0.040 |
Why?
|
| Factor VIIa | 1 | 1999 | 103 | 0.040 |
Why?
|
| Tissue Engineering | 3 | 2006 | 1893 | 0.040 |
Why?
|
| Histone Code | 1 | 2019 | 160 | 0.040 |
Why?
|
| Isomerism | 1 | 1998 | 198 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2010 | 1986 | 0.040 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2019 | 113 | 0.040 |
Why?
|
| Probucol | 1 | 1998 | 25 | 0.040 |
Why?
|
| Finite Element Analysis | 1 | 2021 | 442 | 0.040 |
Why?
|
| Bacterial Adhesion | 1 | 2000 | 305 | 0.040 |
Why?
|
| Virulence | 2 | 2019 | 1297 | 0.040 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 1983 | 1353 | 0.040 |
Why?
|
| Serine | 1 | 2022 | 831 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 1994 | 4363 | 0.040 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2003 | 1567 | 0.040 |
Why?
|
| Acetaminophen | 1 | 2022 | 552 | 0.040 |
Why?
|
| Retinal Vessels | 1 | 2024 | 864 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2020 | 12252 | 0.040 |
Why?
|
| Coloring Agents | 1 | 2001 | 564 | 0.040 |
Why?
|
| Isotretinoin | 1 | 2019 | 134 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2010 | 3048 | 0.040 |
Why?
|
| Saimiri | 3 | 1995 | 337 | 0.040 |
Why?
|
| Prognosis | 3 | 2017 | 30009 | 0.040 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2022 | 827 | 0.040 |
Why?
|
| Epitopes | 4 | 1996 | 2527 | 0.040 |
Why?
|
| Fibrinolysis | 1 | 1999 | 331 | 0.040 |
Why?
|
| Heart Neoplasms | 1 | 2001 | 374 | 0.040 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 1998 | 85 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2017 | 4149 | 0.040 |
Why?
|
| Leishmania donovani | 1 | 1998 | 68 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 2024 | 1880 | 0.040 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2001 | 538 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 1998 | 254 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2003 | 1623 | 0.040 |
Why?
|
| Wnt Proteins | 2 | 1999 | 725 | 0.040 |
Why?
|
| Hemoglobins | 2 | 1997 | 1531 | 0.040 |
Why?
|
| Water | 1 | 2024 | 1421 | 0.040 |
Why?
|
| Caco-2 Cells | 1 | 2018 | 367 | 0.040 |
Why?
|
| Lymphopenia | 1 | 2000 | 300 | 0.040 |
Why?
|
| Leishmaniasis, Visceral | 1 | 1998 | 100 | 0.040 |
Why?
|
| Cardiomegaly | 2 | 2003 | 591 | 0.040 |
Why?
|
| Nitroglycerin | 1 | 1998 | 332 | 0.040 |
Why?
|
| Intestinal Absorption | 1 | 2018 | 401 | 0.030 |
Why?
|
| Reproducibility of Results | 5 | 2018 | 20225 | 0.030 |
Why?
|
| Blotting, Western | 6 | 2007 | 5028 | 0.030 |
Why?
|
| Genes, Protozoan | 4 | 1999 | 170 | 0.030 |
Why?
|
| Enzyme Activation | 3 | 2008 | 3590 | 0.030 |
Why?
|
| Reference Values | 1 | 2004 | 4939 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2023 | 1028 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 2 | 1990 | 542 | 0.030 |
Why?
|
| Hepatocyte Growth Factor | 1 | 1998 | 268 | 0.030 |
Why?
|
| Animals, Newborn | 2 | 1996 | 2683 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2007 | 2956 | 0.030 |
Why?
|
| Polymers | 1 | 2024 | 1630 | 0.030 |
Why?
|
| Mercury | 1 | 1979 | 289 | 0.030 |
Why?
|
| Gated Blood-Pool Imaging | 1 | 1996 | 44 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2019 | 948 | 0.030 |
Why?
|
| Mice, Mutant Strains | 3 | 2009 | 1754 | 0.030 |
Why?
|
| Stents | 2 | 2021 | 3197 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2017 | 369 | 0.030 |
Why?
|
| Organelles | 1 | 1998 | 265 | 0.030 |
Why?
|
| Child, Preschool | 12 | 2006 | 42669 | 0.030 |
Why?
|
| Myosin Light Chains | 1 | 1996 | 122 | 0.030 |
Why?
|
| Venules | 1 | 1996 | 161 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2022 | 3056 | 0.030 |
Why?
|
| Carcinoma, Embryonal | 1 | 1996 | 36 | 0.030 |
Why?
|
| E-Selectin | 2 | 1996 | 577 | 0.030 |
Why?
|
| Polydactyly | 1 | 1996 | 57 | 0.030 |
Why?
|
| Thromboembolism | 1 | 2003 | 1004 | 0.030 |
Why?
|
| Casein Kinase I | 1 | 2016 | 46 | 0.030 |
Why?
|
| Complement C3 | 2 | 1996 | 434 | 0.030 |
Why?
|
| Hernia, Diaphragmatic | 1 | 1997 | 244 | 0.030 |
Why?
|
| CHO Cells | 3 | 2007 | 1379 | 0.030 |
Why?
|
| Carrier Proteins | 3 | 2019 | 4939 | 0.030 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 1996 | 184 | 0.030 |
Why?
|
| France | 1 | 2017 | 497 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2005 | 1712 | 0.030 |
Why?
|
| RNA, Antisense | 1 | 1996 | 136 | 0.030 |
Why?
|
| Binding Sites, Antibody | 2 | 1989 | 340 | 0.030 |
Why?
|
| Casein Kinase II | 1 | 2016 | 121 | 0.030 |
Why?
|
| Immunoglobulin M | 2 | 1984 | 1528 | 0.030 |
Why?
|
| DNA, Protozoan | 4 | 1998 | 227 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 4 | 1997 | 6124 | 0.030 |
Why?
|
| Nephrosis | 1 | 1995 | 43 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2022 | 1361 | 0.030 |
Why?
|
| Hydrogels | 1 | 2021 | 744 | 0.030 |
Why?
|
| Species Specificity | 6 | 2000 | 2415 | 0.030 |
Why?
|
| Immunodominant Epitopes | 1 | 1996 | 244 | 0.030 |
Why?
|
| Plasmodium chabaudi | 1 | 1994 | 19 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2021 | 1319 | 0.030 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 1995 | 142 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 1994 | 5863 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 2001 | 1478 | 0.030 |
Why?
|
| Renal Circulation | 1 | 1995 | 291 | 0.030 |
Why?
|
| Bacterial Proteins | 2 | 2001 | 3840 | 0.030 |
Why?
|
| Receptors, Cytoadhesin | 1 | 1994 | 8 | 0.030 |
Why?
|
| Endocardium | 1 | 1996 | 249 | 0.030 |
Why?
|
| Chaperonins | 1 | 1994 | 58 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 3 | 1999 | 1703 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 1998 | 656 | 0.030 |
Why?
|
| Endothelial Growth Factors | 1 | 1997 | 672 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 1999 | 1525 | 0.030 |
Why?
|
| Peyer's Patches | 1 | 1994 | 120 | 0.030 |
Why?
|
| Adolescent | 13 | 2006 | 89169 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2020 | 2065 | 0.030 |
Why?
|
| Microvilli | 1 | 1994 | 235 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 1998 | 564 | 0.030 |
Why?
|
| Immune Sera | 5 | 1981 | 605 | 0.030 |
Why?
|
| Triglycerides | 4 | 1996 | 2464 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 1998 | 990 | 0.030 |
Why?
|
| Lymphokines | 1 | 1997 | 925 | 0.030 |
Why?
|
| Acute Disease | 2 | 2003 | 7243 | 0.030 |
Why?
|
| Erythrocyte Membrane | 2 | 1993 | 438 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1997 | 792 | 0.030 |
Why?
|
| Inclusion Bodies | 1 | 1975 | 278 | 0.030 |
Why?
|
| Genes | 1 | 1997 | 1824 | 0.030 |
Why?
|
| Ductus Arteriosus | 1 | 1993 | 42 | 0.030 |
Why?
|
| Osteopontin | 1 | 2015 | 311 | 0.030 |
Why?
|
| Cicatrix, Hypertrophic | 1 | 2014 | 80 | 0.030 |
Why?
|
| Protozoan Vaccines | 1 | 1993 | 13 | 0.030 |
Why?
|
| Retina | 1 | 2024 | 2662 | 0.030 |
Why?
|
| Models, Animal | 1 | 2020 | 2122 | 0.030 |
Why?
|
| Consensus | 2 | 2019 | 3211 | 0.030 |
Why?
|
| Retroperitoneal Fibrosis | 1 | 1993 | 42 | 0.030 |
Why?
|
| G(M1) Ganglioside | 1 | 1993 | 87 | 0.030 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2015 | 199 | 0.030 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2013 | 186 | 0.030 |
Why?
|
| Nuclear Proteins | 3 | 2023 | 5804 | 0.030 |
Why?
|
| Mitral Valve | 1 | 2001 | 1475 | 0.030 |
Why?
|
| Interleukin-1 | 1 | 1997 | 1252 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2019 | 1367 | 0.030 |
Why?
|
| Alkynes | 1 | 2013 | 326 | 0.030 |
Why?
|
| Dissection | 1 | 2014 | 299 | 0.030 |
Why?
|
| Motor Neuron Disease | 1 | 1993 | 98 | 0.030 |
Why?
|
| Homeodomain Proteins | 2 | 2019 | 2430 | 0.030 |
Why?
|
| Color | 1 | 2014 | 296 | 0.030 |
Why?
|
| Gangliosides | 1 | 1993 | 132 | 0.030 |
Why?
|
| Affinity Labels | 1 | 1992 | 107 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2019 | 1758 | 0.030 |
Why?
|
| Dirofilariasis | 2 | 1983 | 3 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2001 | 5432 | 0.030 |
Why?
|
| Indoles | 1 | 2001 | 1836 | 0.030 |
Why?
|
| Catheterization | 2 | 2014 | 1430 | 0.030 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2013 | 267 | 0.030 |
Why?
|
| Vimentin | 2 | 2004 | 257 | 0.030 |
Why?
|
| Immunity | 1 | 2018 | 1003 | 0.030 |
Why?
|
| Prednisolone | 1 | 1993 | 326 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 1994 | 794 | 0.030 |
Why?
|
| Exons | 1 | 1998 | 2394 | 0.030 |
Why?
|
| Infant, Newborn | 4 | 2024 | 26421 | 0.030 |
Why?
|
| Graft Rejection | 2 | 1996 | 4492 | 0.030 |
Why?
|
| Cross Reactions | 3 | 1999 | 828 | 0.030 |
Why?
|
| Adiponectin | 1 | 2018 | 1117 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 1998 | 1750 | 0.020 |
Why?
|
| Colitis, Ulcerative | 1 | 2024 | 1926 | 0.020 |
Why?
|
| RANK Ligand | 1 | 2013 | 321 | 0.020 |
Why?
|
| Membrane Lipids | 1 | 2013 | 252 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 2040 | 0.020 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2001 | 1415 | 0.020 |
Why?
|
| Phosphatidylserines | 1 | 2013 | 186 | 0.020 |
Why?
|
| Phosphorus | 1 | 2013 | 336 | 0.020 |
Why?
|
| Molecular Imaging | 1 | 2019 | 826 | 0.020 |
Why?
|
| Durapatite | 1 | 2013 | 167 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 1988 | 945 | 0.020 |
Why?
|
| Transplantation, Homologous | 4 | 2004 | 4834 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2018 | 22290 | 0.020 |
Why?
|
| Receptor, Insulin | 1 | 2015 | 839 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2024 | 2295 | 0.020 |
Why?
|
| Antibody Specificity | 2 | 1994 | 1065 | 0.020 |
Why?
|
| Chemokines | 2 | 2008 | 963 | 0.020 |
Why?
|
| Macaca fascicularis | 2 | 2006 | 912 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 1999 | 1408 | 0.020 |
Why?
|
| Mice, Inbred C3H | 2 | 2009 | 915 | 0.020 |
Why?
|
| Homeostasis | 1 | 2022 | 3348 | 0.020 |
Why?
|
| Stomach Neoplasms | 1 | 2001 | 1481 | 0.020 |
Why?
|
| Histamine Release | 1 | 1971 | 134 | 0.020 |
Why?
|
| Child | 13 | 2006 | 80917 | 0.020 |
Why?
|
| Predictive Value of Tests | 3 | 2019 | 15453 | 0.020 |
Why?
|
| Scavenger Receptors, Class B | 2 | 2001 | 85 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2014 | 659 | 0.020 |
Why?
|
| Skin | 1 | 2025 | 4505 | 0.020 |
Why?
|
| Dependovirus | 1 | 2016 | 720 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 1606 | 0.020 |
Why?
|
| Neuraminidase | 1 | 1991 | 195 | 0.020 |
Why?
|
| Receptors, Scavenger | 2 | 2001 | 123 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 3436 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2001 | 4913 | 0.020 |
Why?
|
| Neuroglia | 1 | 1996 | 960 | 0.020 |
Why?
|
| Chloroquine | 1 | 1972 | 276 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2017 | 1758 | 0.020 |
Why?
|
| Hypertension, Renal | 1 | 1970 | 135 | 0.020 |
Why?
|
| ROC Curve | 1 | 2018 | 3628 | 0.020 |
Why?
|
| Sheep | 2 | 2004 | 1451 | 0.020 |
Why?
|
| Microcirculation | 2 | 1993 | 1281 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1996 | 977 | 0.020 |
Why?
|
| Halogenated Diphenyl Ethers | 2 | 2002 | 84 | 0.020 |
Why?
|
| Heart Ventricles | 2 | 2002 | 3841 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2004 | 10763 | 0.020 |
Why?
|
| Blood Proteins | 1 | 1996 | 1191 | 0.020 |
Why?
|
| Prenylation | 1 | 2010 | 37 | 0.020 |
Why?
|
| Acyl Coenzyme A | 1 | 2010 | 56 | 0.020 |
Why?
|
| Mesenteric Arteries | 1 | 1970 | 178 | 0.020 |
Why?
|
| Fluoroscopy | 1 | 2014 | 947 | 0.020 |
Why?
|
| Intestine, Small | 1 | 1996 | 1217 | 0.020 |
Why?
|
| Glycine | 1 | 2013 | 672 | 0.020 |
Why?
|
| Rats, Wistar | 3 | 1999 | 1890 | 0.020 |
Why?
|
| Chemical Precipitation | 2 | 1987 | 175 | 0.020 |
Why?
|
| COS Cells | 2 | 2005 | 1135 | 0.020 |
Why?
|
| Epithelium | 1 | 2014 | 1607 | 0.020 |
Why?
|
| Clinical Trials as Topic | 2 | 2003 | 8052 | 0.020 |
Why?
|
| Immunization | 3 | 1999 | 1219 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2015 | 942 | 0.020 |
Why?
|
| Helminth Proteins | 1 | 1990 | 173 | 0.020 |
Why?
|
| E-Box Elements | 1 | 2009 | 21 | 0.020 |
Why?
|
| Dinoprostone | 3 | 2008 | 597 | 0.020 |
Why?
|
| Histones | 1 | 2019 | 2601 | 0.020 |
Why?
|
| Blood | 1 | 1992 | 599 | 0.020 |
Why?
|
| Transplantation, Heterotopic | 2 | 2003 | 175 | 0.020 |
Why?
|
| Cathepsin K | 1 | 2009 | 65 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 2634 | 0.020 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1996 | 1801 | 0.020 |
Why?
|
| Nonmuscle Myosin Type IIB | 2 | 1999 | 21 | 0.020 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2009 | 79 | 0.020 |
Why?
|
| Mice, Inbred Strains | 2 | 2003 | 1769 | 0.020 |
Why?
|
| Tunica Media | 1 | 2009 | 111 | 0.020 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 1989 | 144 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2018 | 4280 | 0.020 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2009 | 57 | 0.020 |
Why?
|
| Pelvis | 1 | 1993 | 736 | 0.020 |
Why?
|
| Bone Marrow Diseases | 1 | 1971 | 234 | 0.020 |
Why?
|
| Nephrectomy | 2 | 2009 | 930 | 0.020 |
Why?
|
| Calgranulin A | 1 | 2009 | 81 | 0.020 |
Why?
|
| Echocardiography | 4 | 2003 | 5047 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2009 | 455 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 1999 | 2982 | 0.020 |
Why?
|
| Mice, Congenic | 1 | 2008 | 98 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 1992 | 958 | 0.020 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 2008 | 44 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1999 | 3610 | 0.020 |
Why?
|
| Integrins | 1 | 1992 | 842 | 0.020 |
Why?
|
| Radiation Chimera | 1 | 2008 | 216 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 3 | 1995 | 705 | 0.020 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2008 | 93 | 0.020 |
Why?
|
| Chromatin | 1 | 2019 | 2981 | 0.020 |
Why?
|
| Enzyme Precursors | 1 | 2008 | 166 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 2830 | 0.020 |
Why?
|
| Cyclosporins | 1 | 1987 | 216 | 0.020 |
Why?
|
| Cell Migration Inhibition | 1 | 2007 | 97 | 0.020 |
Why?
|
| Cystatin C | 1 | 2009 | 272 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1972 | 1505 | 0.020 |
Why?
|
| Liposomes | 1 | 1991 | 792 | 0.020 |
Why?
|
| Pseudopodia | 2 | 1982 | 167 | 0.020 |
Why?
|
| Norbornanes | 1 | 2006 | 10 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 1999 | 424 | 0.020 |
Why?
|
| Phosphatidylinositol Diacylglycerol-Lyase | 1 | 2006 | 20 | 0.020 |
Why?
|
| Thiocarbamates | 1 | 2006 | 30 | 0.020 |
Why?
|
| Models, Cardiovascular | 2 | 2003 | 981 | 0.020 |
Why?
|
| Proteinuria | 3 | 1995 | 611 | 0.020 |
Why?
|
| Thiones | 1 | 2006 | 51 | 0.020 |
Why?
|
| DNA-Binding Proteins | 3 | 1999 | 9617 | 0.020 |
Why?
|
| Linear Models | 1 | 2017 | 5884 | 0.020 |
Why?
|
| Lung Neoplasms | 2 | 2001 | 13586 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 1991 | 762 | 0.020 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2009 | 257 | 0.020 |
Why?
|
| Calmodulin | 1 | 1987 | 241 | 0.020 |
Why?
|
| Coma | 1 | 1990 | 485 | 0.020 |
Why?
|
| Autopsy | 1 | 1990 | 1011 | 0.020 |
Why?
|
| Superoxides | 2 | 1985 | 389 | 0.020 |
Why?
|
| Cytokines | 2 | 2006 | 7452 | 0.020 |
Why?
|
| Cholesterol, VLDL | 1 | 2006 | 70 | 0.020 |
Why?
|
| Connective Tissue Cells | 1 | 2006 | 50 | 0.020 |
Why?
|
| Thyroid Diseases | 1 | 1969 | 385 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6525 | 0.020 |
Why?
|
| Prostaglandins I | 1 | 2006 | 12 | 0.020 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2008 | 331 | 0.020 |
Why?
|
| Carotid Artery Injuries | 2 | 1998 | 96 | 0.020 |
Why?
|
| Leukotriene B4 | 1 | 2007 | 281 | 0.020 |
Why?
|
| Genotype | 1 | 2001 | 13045 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2015 | 6004 | 0.020 |
Why?
|
| Aged, 80 and over | 4 | 2017 | 59626 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 1997 | 1605 | 0.020 |
Why?
|
| Heart | 2 | 1996 | 4446 | 0.020 |
Why?
|
| Rheology | 1 | 2007 | 348 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2013 | 2003 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 1987 | 513 | 0.020 |
Why?
|
| Kidney | 3 | 1996 | 7064 | 0.020 |
Why?
|
| I-kappa B Proteins | 1 | 2006 | 210 | 0.020 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2006 | 213 | 0.020 |
Why?
|
| Regeneration | 1 | 2014 | 1524 | 0.020 |
Why?
|
| Prostaglandins E | 2 | 1983 | 166 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 1996 | 2138 | 0.020 |
Why?
|
| Acetaldehyde | 1 | 1985 | 39 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2008 | 930 | 0.020 |
Why?
|
| Rats, Mutant Strains | 1 | 1984 | 60 | 0.020 |
Why?
|
| Giardiasis | 1 | 1985 | 28 | 0.020 |
Why?
|
| Cricetulus | 1 | 2007 | 812 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2022 | 54924 | 0.020 |
Why?
|
| Lipoproteins, VLDL | 1 | 2006 | 201 | 0.020 |
Why?
|
| Xanthine Oxidase | 1 | 1985 | 69 | 0.020 |
Why?
|
| Ephrin-B2 | 1 | 2004 | 40 | 0.010 |
Why?
|
| Catalase | 1 | 1985 | 215 | 0.010 |
Why?
|
| Peritonitis | 1 | 2007 | 368 | 0.010 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2006 | 235 | 0.010 |
Why?
|
| Precipitin Tests | 2 | 1999 | 816 | 0.010 |
Why?
|
| Recurrence | 1 | 1997 | 8509 | 0.010 |
Why?
|
| Gene Library | 2 | 1999 | 1064 | 0.010 |
Why?
|
| Heart Valve Prosthesis | 2 | 2004 | 1468 | 0.010 |
Why?
|
| Rats, Inbred F344 | 2 | 1996 | 826 | 0.010 |
Why?
|
| Cell Shape | 1 | 2005 | 371 | 0.010 |
Why?
|
| Anopheles | 2 | 1999 | 193 | 0.010 |
Why?
|
| Nitric Oxide | 2 | 2006 | 2149 | 0.010 |
Why?
|
| Ovum | 1 | 1985 | 187 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 1987 | 687 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2014 | 9016 | 0.010 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2006 | 361 | 0.010 |
Why?
|
| Hemodynamics | 2 | 2005 | 4194 | 0.010 |
Why?
|
| Citric Acid Cycle | 1 | 1985 | 234 | 0.010 |
Why?
|
| Binding, Competitive | 2 | 1999 | 1142 | 0.010 |
Why?
|
| Rats, Inbred Lew | 2 | 1996 | 1163 | 0.010 |
Why?
|
| Survival Rate | 3 | 2003 | 12840 | 0.010 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 1985 | 306 | 0.010 |
Why?
|
| Tomography | 1 | 2006 | 442 | 0.010 |
Why?
|
| Fluorescence | 1 | 2006 | 757 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 3 | 1999 | 4786 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 12077 | 0.010 |
Why?
|
| Dimerization | 1 | 2005 | 887 | 0.010 |
Why?
|
| Creatinine | 1 | 2009 | 1918 | 0.010 |
Why?
|
| Stress, Mechanical | 2 | 2001 | 1680 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2003 | 510 | 0.010 |
Why?
|
| Sex Factors | 1 | 2017 | 10632 | 0.010 |
Why?
|
| Chemokine CCL5 | 1 | 2003 | 214 | 0.010 |
Why?
|
| Lymphocyte Activation | 2 | 2010 | 5505 | 0.010 |
Why?
|
| Granuloma | 1 | 1985 | 329 | 0.010 |
Why?
|
| Cytochalasin B | 1 | 1982 | 74 | 0.010 |
Why?
|
| Arginine Vasopressin | 1 | 1983 | 125 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1996 | 4793 | 0.010 |
Why?
|
| RNA, Protozoan | 2 | 1993 | 46 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1998 | 8543 | 0.010 |
Why?
|
| Ascitic Fluid | 1 | 1983 | 189 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 1985 | 596 | 0.010 |
Why?
|
| Receptors, Complement | 1 | 1983 | 254 | 0.010 |
Why?
|
| Logistic Models | 1 | 2017 | 13290 | 0.010 |
Why?
|
| Flagella | 1 | 1982 | 97 | 0.010 |
Why?
|
| Oxonic Acid | 1 | 2001 | 32 | 0.010 |
Why?
|
| Glycosylation | 1 | 2005 | 1100 | 0.010 |
Why?
|
| Tegafur | 1 | 2001 | 40 | 0.010 |
Why?
|
| Prostaglandins | 1 | 1983 | 398 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2006 | 1207 | 0.010 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2001 | 61 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2008 | 1505 | 0.010 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2001 | 52 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 1985 | 741 | 0.010 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 1982 | 187 | 0.010 |
Why?
|
| Blotting, Northern | 2 | 1995 | 1553 | 0.010 |
Why?
|
| Osteoblasts | 1 | 2007 | 1153 | 0.010 |
Why?
|
| Cardiac Volume | 1 | 2002 | 197 | 0.010 |
Why?
|
| Immunoglobulin A | 1 | 1985 | 992 | 0.010 |
Why?
|
| Glomerular Mesangium | 2 | 1995 | 98 | 0.010 |
Why?
|
| Hypertension | 1 | 2001 | 8616 | 0.010 |
Why?
|
| Ligation | 1 | 2002 | 446 | 0.010 |
Why?
|
| Carcinoma, Large Cell | 1 | 2001 | 114 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 1996 | 4262 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1993 | 781 | 0.010 |
Why?
|
| Kidney Tubules | 1 | 1983 | 454 | 0.010 |
Why?
|
| Rats, Inbred WKY | 2 | 1995 | 150 | 0.010 |
Why?
|
| Nephrotic Syndrome | 1 | 1984 | 381 | 0.010 |
Why?
|
| Antimalarials | 1 | 1987 | 909 | 0.010 |
Why?
|
| Thrombophilia | 1 | 2003 | 308 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2005 | 1864 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2001 | 11878 | 0.010 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2001 | 153 | 0.010 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2004 | 892 | 0.010 |
Why?
|
| Infant | 7 | 2006 | 36535 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2001 | 766 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2006 | 2227 | 0.010 |
Why?
|
| Lung | 2 | 1996 | 10101 | 0.010 |
Why?
|
| Insect Vectors | 1 | 2001 | 136 | 0.010 |
Why?
|
| Dilatation, Pathologic | 1 | 2002 | 527 | 0.010 |
Why?
|
| Blood Platelets | 1 | 1971 | 2479 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2019 | 12795 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2001 | 575 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2008 | 2222 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2000 | 150 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1981 | 1309 | 0.010 |
Why?
|
| BCG Vaccine | 1 | 1983 | 381 | 0.010 |
Why?
|
| Glycosuria | 1 | 1979 | 44 | 0.010 |
Why?
|
| Bone Marrow | 2 | 2001 | 2935 | 0.010 |
Why?
|
| Endotoxins | 1 | 1982 | 519 | 0.010 |
Why?
|
| Hemolysis | 1 | 1982 | 417 | 0.010 |
Why?
|
| Complement System Proteins | 1 | 1983 | 738 | 0.010 |
Why?
|
| Losartan | 1 | 2001 | 262 | 0.010 |
Why?
|
| Endopeptidases | 1 | 2003 | 764 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 2000 | 217 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2004 | 2125 | 0.010 |
Why?
|
| Frizzled Receptors | 1 | 1999 | 90 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2003 | 1441 | 0.010 |
Why?
|
| Receptors, Fc | 1 | 1983 | 537 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 2001 | 663 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2006 | 1312 | 0.010 |
Why?
|
| Lymphocyte Subsets | 1 | 2000 | 313 | 0.010 |
Why?
|
| Leishmania infantum | 1 | 1998 | 17 | 0.010 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2001 | 394 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1983 | 1470 | 0.010 |
Why?
|
| Models, Chemical | 1 | 2000 | 611 | 0.010 |
Why?
|
| Papillary Muscles | 1 | 1999 | 192 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 1999 | 557 | 0.010 |
Why?
|
| Vacuoles | 1 | 1999 | 224 | 0.010 |
Why?
|
| Mice, SCID | 2 | 1994 | 2627 | 0.010 |
Why?
|
| Incidence | 1 | 2017 | 21538 | 0.010 |
Why?
|
| DNA Probes | 1 | 1999 | 542 | 0.010 |
Why?
|
| Age Factors | 4 | 1999 | 18415 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 1998 | 260 | 0.010 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2001 | 423 | 0.010 |
Why?
|
| Hot Temperature | 2 | 1997 | 1440 | 0.010 |
Why?
|
| Photoplethysmography | 1 | 1998 | 66 | 0.010 |
Why?
|
| Larva | 1 | 1980 | 515 | 0.010 |
Why?
|
| Genes, Essential | 1 | 1999 | 185 | 0.010 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2001 | 646 | 0.010 |
Why?
|
| Haplorhini | 2 | 1976 | 523 | 0.010 |
Why?
|
| Antibodies, Antinuclear | 1 | 1979 | 342 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1998 | 383 | 0.010 |
Why?
|
| Heparin | 1 | 1985 | 1636 | 0.010 |
Why?
|
| Bioprosthesis | 1 | 2002 | 593 | 0.010 |
Why?
|
| Genomic Library | 1 | 1997 | 189 | 0.010 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2000 | 567 | 0.010 |
Why?
|
| Cell Size | 1 | 1999 | 626 | 0.010 |
Why?
|
| Syndrome | 1 | 2003 | 3273 | 0.010 |
Why?
|
| Neurons | 1 | 1996 | 9514 | 0.010 |
Why?
|
| Carcinogens | 1 | 1999 | 453 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 1999 | 577 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 17142 | 0.010 |
Why?
|
| Gestational Age | 1 | 2006 | 3621 | 0.010 |
Why?
|
| Rats, Inbred Strains | 2 | 1984 | 2087 | 0.010 |
Why?
|
| Aspirin | 2 | 2006 | 3135 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 859 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 2 | 1998 | 3740 | 0.010 |
Why?
|
| Systole | 1 | 1999 | 937 | 0.010 |
Why?
|
| Nerve Tissue | 1 | 1996 | 78 | 0.010 |
Why?
|
| Hybridomas | 1 | 1997 | 444 | 0.010 |
Why?
|
| Apicomplexa | 1 | 1976 | 9 | 0.010 |
Why?
|
| Haptoglobins | 1 | 1997 | 165 | 0.010 |
Why?
|
| Chlorides | 1 | 1979 | 666 | 0.010 |
Why?
|
| Pressure | 1 | 1999 | 1172 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2003 | 1542 | 0.010 |
Why?
|
| POU Domain Factors | 1 | 1996 | 47 | 0.010 |
Why?
|
| Antioxidants | 1 | 2004 | 1676 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1997 | 1084 | 0.010 |
Why?
|
| Cells | 1 | 1977 | 166 | 0.010 |
Why?
|
| Pan troglodytes | 1 | 1996 | 224 | 0.010 |
Why?
|
| Puromycin Aminonucleoside | 1 | 1995 | 7 | 0.010 |
Why?
|
| Solubility | 1 | 1997 | 1086 | 0.010 |
Why?
|
| Freeze Fracturing | 1 | 1975 | 70 | 0.010 |
Why?
|
| Vasoconstriction | 1 | 1998 | 592 | 0.010 |
Why?
|
| Cisplatin | 1 | 2001 | 1660 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 1997 | 749 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2001 | 2089 | 0.010 |
Why?
|
| Basement Membrane | 1 | 1996 | 348 | 0.010 |
Why?
|
| RNA Probes | 1 | 1995 | 111 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1990 | 13013 | 0.010 |
Why?
|
| Prosthesis Design | 1 | 2002 | 2125 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2005 | 5902 | 0.010 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1995 | 79 | 0.010 |
Why?
|
| Phagocytes | 1 | 1996 | 294 | 0.010 |
Why?
|
| Introns | 1 | 1997 | 965 | 0.010 |
Why?
|
| Arterioles | 1 | 1995 | 251 | 0.010 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2001 | 1065 | 0.010 |
Why?
|
| Angioplasty, Balloon | 1 | 1998 | 593 | 0.010 |
Why?
|
| Immunoglobulin Isotypes | 1 | 1994 | 158 | 0.010 |
Why?
|
| Plasmids | 1 | 1999 | 2269 | 0.010 |
Why?
|
| Gene Dosage | 1 | 1998 | 1219 | 0.010 |
Why?
|
| Blood Cells | 1 | 1995 | 309 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2005 | 4541 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2001 | 4861 | 0.010 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 1995 | 303 | 0.010 |
Why?
|
| Aotus trivirgatus | 1 | 1993 | 35 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 1998 | 1715 | 0.010 |
Why?
|
| Umbilical Arteries | 1 | 1993 | 77 | 0.010 |
Why?
|
| Renin | 1 | 1995 | 648 | 0.010 |
Why?
|
| Sclerosis | 1 | 1993 | 211 | 0.010 |
Why?
|
| Nerve Fibers | 1 | 1996 | 709 | 0.010 |
Why?
|
| Observer Variation | 1 | 1999 | 2621 | 0.010 |
Why?
|
| Dirofilaria immitis | 2 | 1983 | 8 | 0.010 |
Why?
|
| Biological Products | 1 | 2002 | 947 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1993 | 849 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2007 | 18065 | 0.010 |
Why?
|
| Ferritins | 1 | 1975 | 601 | 0.010 |
Why?
|
| China | 1 | 1998 | 2395 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 1992 | 425 | 0.010 |
Why?
|
| Serotonin | 1 | 1996 | 1043 | 0.010 |
Why?
|
| Tritium | 1 | 1972 | 707 | 0.010 |
Why?
|
| Ammonium Chloride | 1 | 1991 | 72 | 0.010 |
Why?
|
| Lipid A | 1 | 1991 | 70 | 0.010 |
Why?
|
| Canaries | 1 | 1971 | 6 | 0.010 |
Why?
|
| Salivary Glands | 1 | 1993 | 231 | 0.010 |
Why?
|
| Autoradiography | 1 | 1972 | 728 | 0.010 |
Why?
|
| Rest | 1 | 1996 | 948 | 0.010 |
Why?
|
| Glycoside Hydrolases | 1 | 1991 | 135 | 0.010 |
Why?
|
| Acid Phosphatase | 1 | 1971 | 141 | 0.010 |
Why?
|
| Constriction | 1 | 1970 | 168 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1975 | 1080 | 0.010 |
Why?
|
| Schistosomiasis | 1 | 1971 | 65 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1981 | 2100 | 0.010 |
Why?
|
| Vaccines, Synthetic | 1 | 1993 | 622 | 0.010 |
Why?
|
| Uric Acid | 1 | 1996 | 805 | 0.010 |
Why?
|
| Multigene Family | 1 | 1993 | 1081 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2001 | 3474 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1990 | 636 | 0.010 |
Why?
|
| Golgi Apparatus | 1 | 1991 | 406 | 0.010 |
Why?
|
| Agglutination | 2 | 1981 | 42 | 0.000 |
Why?
|
| Diabetic Nephropathies | 1 | 1996 | 973 | 0.000 |
Why?
|
| Leupeptins | 1 | 1988 | 113 | 0.000 |
Why?
|
| Hypertrophy | 1 | 1970 | 562 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1990 | 1305 | 0.000 |
Why?
|
| Melanoma | 2 | 1989 | 5706 | 0.000 |
Why?
|
| Exercise Test | 1 | 1996 | 2186 | 0.000 |
Why?
|
| Epithelial Cells | 1 | 2000 | 3703 | 0.000 |
Why?
|
| Immunotherapy | 1 | 1984 | 4754 | 0.000 |
Why?
|
| Mass Screening | 1 | 2003 | 5458 | 0.000 |
Why?
|
| Antigens, Viral | 1 | 1991 | 995 | 0.000 |
Why?
|
| Leucine | 1 | 1988 | 547 | 0.000 |
Why?
|
| Dogs | 2 | 1983 | 3845 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 2001 | 11244 | 0.000 |
Why?
|
| Necrosis | 1 | 1970 | 1616 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1998 | 4213 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2001 | 4058 | 0.000 |
Why?
|
| Giardia | 1 | 1985 | 7 | 0.000 |
Why?
|
| Blood Urea Nitrogen | 1 | 1984 | 189 | 0.000 |
Why?
|
| Pulmonary Artery | 1 | 1993 | 1946 | 0.000 |
Why?
|
| Transplantation, Heterologous | 1 | 1993 | 2393 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 2001 | 6395 | 0.000 |
Why?
|
| Prostaglandins F | 1 | 1983 | 80 | 0.000 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 1 | 1983 | 80 | 0.000 |
Why?
|
| Ventricular Function, Left | 1 | 1996 | 3941 | 0.000 |
Why?
|
| Calcimycin | 1 | 1983 | 214 | 0.000 |
Why?
|
| Protein Biosynthesis | 1 | 1990 | 2094 | 0.000 |
Why?
|
| Opsonin Proteins | 1 | 1983 | 144 | 0.000 |
Why?
|
| Contrast Media | 1 | 1996 | 5330 | 0.000 |
Why?
|
| Drug Interactions | 1 | 1987 | 1419 | 0.000 |
Why?
|
| Dinoprost | 1 | 1983 | 139 | 0.000 |
Why?
|
| Arachidonic Acids | 1 | 1983 | 296 | 0.000 |
Why?
|
| Hypotonic Solutions | 1 | 1982 | 48 | 0.000 |
Why?
|
| Chlordiazepoxide | 1 | 1962 | 42 | 0.000 |
Why?
|
| Alprostadil | 1 | 1982 | 86 | 0.000 |
Why?
|
| Tranquilizing Agents | 1 | 1962 | 60 | 0.000 |
Why?
|
| Sphingomyelins | 1 | 1982 | 105 | 0.000 |
Why?
|
| Drug Resistance | 1 | 1987 | 1599 | 0.000 |
Why?
|
| Arachidonic Acid | 1 | 1983 | 429 | 0.000 |
Why?
|
| Amnion | 1 | 1982 | 204 | 0.000 |
Why?
|
| Granulocytes | 1 | 1983 | 551 | 0.000 |
Why?
|
| Liver Transplantation | 1 | 1993 | 2401 | 0.000 |
Why?
|
| Vaccination | 1 | 1993 | 3437 | 0.000 |
Why?
|
| Phosphatidylcholines | 1 | 1982 | 406 | 0.000 |
Why?
|
| Quality of Life | 1 | 2001 | 13490 | 0.000 |
Why?
|
| Endothelium | 1 | 1982 | 768 | 0.000 |
Why?
|
| Glucose | 1 | 1991 | 4352 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 2000 | 26379 | 0.000 |
Why?
|
| Neuroblastoma | 1 | 1966 | 1266 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2000 | 41753 | 0.000 |
Why?
|
| Immunity, Cellular | 1 | 1983 | 1561 | 0.000 |
Why?
|
| Pronase | 1 | 1976 | 28 | 0.000 |
Why?
|
| Electroconvulsive Therapy | 1 | 1962 | 504 | 0.000 |
Why?
|
| Mice, Inbred A | 1 | 1976 | 245 | 0.000 |
Why?
|
| Cattle | 1 | 1982 | 3819 | 0.000 |
Why?
|
| Microscopy, Interference | 1 | 1975 | 35 | 0.000 |
Why?
|
| Trypsin | 1 | 1976 | 491 | 0.000 |
Why?
|
| Cell Aggregation | 1 | 1975 | 238 | 0.000 |
Why?
|
| Formaldehyde | 1 | 1976 | 361 | 0.000 |
Why?
|
| Immunoglobulins | 1 | 1976 | 855 | 0.000 |
Why?
|
| Psychotherapy | 1 | 1962 | 1654 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1993 | 20762 | 0.000 |
Why?
|
| Psychiatry | 1 | 1962 | 1716 | 0.000 |
Why?
|
| Temperature | 1 | 1976 | 2234 | 0.000 |
Why?
|
| Glycoproteins | 1 | 1975 | 2202 | 0.000 |
Why?
|
| Japan | 1 | 1966 | 1418 | 0.000 |
Why?
|
| Mental Disorders | 1 | 1962 | 6873 | 0.000 |
Why?
|
| Neoplasms | 1 | 1982 | 22371 | 0.000 |
Why?
|